Changes in Relevant for UDS 2026
Last updated June 29, 2026
We are currently reviewing the Program Assistance Letter and planning changes to the UDS module.
Timeline of updates
- Afternoon of April 20, 2026. we will enable the UDS 2026 measures for all health centers.
- April–May 2026. We will refresh the CQM Value Sets and RxNorm Value Set.
- Spring 2026 onward. We will incrementally update the UDS module logic.
Table 6A: Selected Services Rendered
Line Additions
May 2026. We added support for the new Table 6A Selected Diagnoses lines:
| Line | Service | Counted by |
|---|---|---|
| 26g | Autism Spectrum Disorder (ASD) screenings | Autism Spectrum Disorder Screens |
Line Removals
May 2026. We removed Table 6A Selected Services lines that are no longer required per the 2026 Program Assistance Letter:
| Line | Service |
|---|---|
| 21c | Novel coronavirus (SARS-CoV-2) diagnostic test |
| 21d | Novel coronavirus (SARS-CoV-2) antibody test |
| 22 | Mammogram |
| 23 | Pap test |
| 30 | Sealants |
| 33 | Oral surgery |
| 34 | Rehabilitative services |
Line Revisions
May 2026. Line 26, Health supervision of infant or child (ages 0 through 11), was renamed to Well Child Visits (ages 0 through 11). We also updated Relevant to count this line using the Well Child Interventions Data Element instead of Visit Billing or Diagnosis Codes for patients under age 12 at the start of the intervention. The data element itself does not require a linked visit, but the patient must still qualify for UDS reporting in the reporting year to be included in Table 6A.
Table 6A: Selected Diagnoses
Line Additions
May 2026. We added support for the new Table 6A Selected Diagnoses lines:
| Line | Diagnosis | Counted by |
|---|---|---|
| 9a | Diabetes mellitus type 1 | ICD-10 diagnosis codes in the E10* range |
| 20g | Intellectual and developmental disabilities | ICD-10 diagnosis codes in the F70* through F89* range |
Line Removals
May 2026. We removed Table 6A Selected Diagnoses lines that are no longer required per the 2026 Program Assistance Letter:
| Line | Diagnosis |
|---|---|
| 4c | Novel coronavirus (SARS-CoV-2) disease |
| 4d | Long COVID |
| 6a | Respiratory conditions related to COVID-19 |
| 7 | Abnormal breast cancer findings, female |
| 8 | Abnormal cervical findings |
| 12 | Contact dermatitis and other eczema |
Table 6B: Quality of Care Measures
Line Revisions
June 2026. We updated Table 6B Section M to replace the old line 22, Dental Sealants for Children between 6-9 Years, with the two 2026 measures from the Program Assistance Letter:
These updates may be refined once the final UDS Manual is published; the underlying measure SQL may change accordingly.
| Line | Measure |
|---|---|
| 22a | Sealant Receipt on Permanent First Molars: Rate 1 At Least One Sealant |
| 22b | Sealant Receipt on Permanent First Molars: Rate 2 All Four Molars Sealed |